Purpose: This study was designed to evaluate the feasibility of using a targeted array-CGH strategy for prenatal diagnosis of genomic imbalances in a clinical setting of current pregnancies. Methods: ...

Microarray-based comparative genomic hybridization (CGH microarray) is an evolving technology for the rapid multiplex detection of genomic imbalances. 1 This diagnostic strategy has contributed to our ...

infoQuant Ltd brings microarray technology closer to clinical use with its latest release of copy number analysis and interpretation software "oneClickCGH" and "CGH Fusion" for microarray-based ...

Oxford, UK – 10th December 2009. Oxford Gene Technology (OGT), the pioneer of microarray-based technologies, has introduced its new CytoSure™ Interpret software, for faster and easier translation of ...

Microarray-based Comparative Genomic Hybridization (array-CGH) has been applied for a decade to screen for submicroscopic DNA gains and losses in tumor and constitutional DNA samples. This method has ...

Agilent Technologiesの日本法人であるアジレント・テクノロジーは、ガン研究者や疾病と遺伝的要素の関連解析、高度医療における新しい分子診断法の開発を行っている研究者向けに第3世代マイクロアレイ「SurePrint G3 マイクロアレイ」を発表、4月1日からの販売 ...

Early efforts to examine genomic changes in the clinical setting relied on cytogenetic techniques such as chromosome karyotyping, a widely used approach to examine chromosomes and identify changes ...

Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...

Agilent Technologiesと、細胞株の評価・品質保証サービスを提供するCell Line Genetics(CLG)は、再生医療やがん研究に向けた高スループットのゲノム評価ワークフローの開発を行い、細胞株の完全性の確認やモニターを行えるような体制の構築を目指し協力していく ...

オリゴヌクレオチドマイクロアレイを遺伝子発現研究だけに用いる時代は過ぎ去った。むしろ、例えば遺伝子型判定でマイクロアレイの果たす機能などの方が、もともとの用途よりも重要な意味を持つようになったといえるのではないだろうか。最近発表さ ...